231 related articles for article (PubMed ID: 17336913)
1. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy.
Yodoi Y; Tsujikawa A; Kameda T; Otani A; Tamura H; Mandai M; Yoshimura N
Am J Ophthalmol; 2007 Jun; 143(6):984-994. PubMed ID: 17336913
[TBL] [Abstract][Full Text] [Related]
2. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
Maruko I; Iida T; Sugano Y; Saito M; Sekiryu T
Am J Ophthalmol; 2011 Apr; 151(4):594-603.e1. PubMed ID: 21295766
[TBL] [Abstract][Full Text] [Related]
3. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.
Tomita K; Tsujikawa A; Yamashiro K; Ooto S; Tamura H; Otani A; Nakayama Y; Yoshimura N
Am J Ophthalmol; 2012 Jan; 153(1):68-80.e1. PubMed ID: 21907965
[TBL] [Abstract][Full Text] [Related]
4. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.
Lee YH; Lee EK; Shin KS; Lee KM; Kim JY
Retina; 2011; 31(7):1287-93. PubMed ID: 21386762
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of combined photodynamic therapy and intravitreal bevacizumab injection versus photodynamic therapy alone in polypoidal choroidal vasculopathy.
Kim SJ; Yu HG
Retina; 2011 Oct; 31(9):1827-34. PubMed ID: 21734621
[TBL] [Abstract][Full Text] [Related]
8. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
Yamashita A; Shiraga F; Shiragami C; Ono A; Tenkumo K
Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
Saito M; Iida T; Kano M
Retina; 2011 Sep; 31(8):1589-97. PubMed ID: 21654347
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
Leal S; Silva R; Figueira J; Cachulo ML; Pires I; de Abreu JR; Cunha-Vaz JG
Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
[TBL] [Abstract][Full Text] [Related]
11. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
Yamashita A; Shiraga F; Shiragami C; Shirakata Y; Fujiwara A
Am J Ophthalmol; 2013 Jan; 155(1):96-102.e1. PubMed ID: 22995028
[TBL] [Abstract][Full Text] [Related]
12. Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.
Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Tano Y
Br J Ophthalmol; 2008 Jul; 92(7):936-40. PubMed ID: 18577645
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
Lai TY; Lee GK; Luk FO; Lam DS
Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.
Hirami Y; Tsujikawa A; Otani A; Yodoi Y; Aikawa H; Mandai M; Yoshimura N
Retina; 2007 Mar; 27(3):335-41. PubMed ID: 17460589
[TBL] [Abstract][Full Text] [Related]
15. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
[TBL] [Abstract][Full Text] [Related]
16. Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.
Kang HM; Kim YM; Koh HJ
Am J Ophthalmol; 2013 Mar; 155(3):438-447.e1. PubMed ID: 23218705
[TBL] [Abstract][Full Text] [Related]
17. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.
Sato T; Kishi S; Matsumoto H; Mukai R
Am J Ophthalmol; 2010 Jun; 149(6):947-954.e1. PubMed ID: 20346441
[TBL] [Abstract][Full Text] [Related]
18. Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
Chan WM; Liu DT; Lai TY; Li H; Tong JP; Lam DS
Clin Exp Ophthalmol; 2005 Dec; 33(6):611-8. PubMed ID: 16402954
[TBL] [Abstract][Full Text] [Related]
19. Role of photodynamic therapy in polypoidal choroidal vasculopathy.
Akaza E; Yuzawa M; Matsumoto Y; Kashiwakura S; Fujita K; Mori R
Jpn J Ophthalmol; 2007; 51(4):270-7. PubMed ID: 17660987
[TBL] [Abstract][Full Text] [Related]
20. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.
Silva RM; Figueira J; Cachulo ML; Duarte L; Faria de Abreu JR; Cunha-Vaz JG
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):973-9. PubMed ID: 15864616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
